Metastatic renal cell carcinoma treated with pazopanib after progression on other targeted agents: A single-institution experience.
Marc R. Matrana
No relevant relationships to disclose
Bradley J. Atkinson
No relevant relationships to disclose
Paul G. Corn
No relevant relationships to disclose
Eric Jonasch
No relevant relationships to disclose
Nizar M. Tannir
No relevant relationships to disclose